本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Quoin Pharmaceuticals

6.79
-0.1100-1.59%
盤前6.63-0.1636-2.41%05:06 EDT
成交量:6.57萬
成交額:44.30萬
市值:1,363.70萬
市盈率:-0.80
高:6.87
開:6.87
低:6.66
收:6.90
52周最高:41.80
52周最低:3.25
股本:200.84萬
流通股本:130.24萬
量比:0.41
換手率:5.04%
股息:- -
股息率:- -
每股收益(TTM):-8.5210
每股收益(LYR):-14.7963
淨資產收益率:-575.73%
總資產收益率:-114.60%
市淨率:3.47
市盈率(LYR):-0.46

資料載入中...

2023/02/09

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2023/02/08

SEC問詢函

CORRESP [Cover] - Correspondence
2023/02/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2022/08/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/08/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/04

SEC問詢函

CORRESP [Cover] - Correspondence
2022/08/04

[修訂]招股説明書

F-1/A [Amend] - Registration statement for certain foreign private issuers
2022/08/03

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/04/22

SEC問詢函

CORRESP [Cover] - Correspondence
2022/04/15

招股説明書

F-1 - Registration statement for certain foreign private issuers
2022/04/14

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/12

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/08/10

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/03

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2021/07/16

SEC問詢函

CORRESP [Cover] - Correspondence
2021/03/29

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals